Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 18Sarcoma 3Lymphoid 2Gynecologic 2Dermatologic 2Breast 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Genitourinary 1

Conditions

Multiple Myeloma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms, Plasma Cell 5Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Acute 5Leukemia, Lymphocytic, Chronic, B-Cell 5Myelodysplastic Syndromes 4Lymphoma, Mantle-Cell 4Lymphoma, Follicular 4Lymphoma 4Leukemia 4Hodgkin Disease 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Myelomonocytic, Chronic 3Hematologic Neoplasms 3Burkitt Lymphoma 3Recurrence 2Primary Myelofibrosis 2Ovarian Neoplasms 2Myeloproliferative Disorders 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Hairy Cell 2Leukemia, Biphenotypic, Acute 2Dendritic Cell Sarcoma, Interdigitating 2Breast Neoplasms 2

Interventions

Flow Cytometry 6Cyclophosphamide 5Therapeutics 4Polymerase Chain Reaction 3Immunologic Techniques 3Amplified Fragment Length Polymorphism Analysis 3liposomal amphotericin B 2Voriconazole 2Psychiatric Rehabilitation 2Peripheral Blood Stem Cell Transplantation 2Ondansetron 2Methylprednisolone 2Melphalan 2Itraconazole 2Dexamethasone 2Deferasirox 2Caspofungin 2Calcium Dobesilate 2Aprepitant 2Analgesia 2Alemtuzumab 2thymoglobulin 1sargramostim 1molibresib 1fludarabine 1dexamethasone acetate 1dexamethasone 21-phosphate 1ceritinib 1aldesleukin 1Whole-Body Irradiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroblastoma × aldesleukin × Plasma cell × Clear all
NCT00003408 2013-03-26

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

National Cancer Institute (NCI)

Phase 2 Completed
40 enrolled
BreastCNSDermatologicGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Teratoma, Testicular, Testicular Germ Cell Tumor, Carcinoma, Ovarian Epithelial, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Kidney Neoplasms, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Recurrence, Sarcoma, Sezary Syndrome, Teratoma, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Gestational Trophoblastic Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡